HETEROBICYCLIC COMPOUNDS HAVING ANTIINFLAMMATORY ACTIVITY
申请人:SCHERING CORPORATION
公开号:EP0419561A1
公开(公告)日:1991-04-03
US5182289A
申请人:——
公开号:US5182289A
公开(公告)日:1993-01-26
[EN] HETEROBICYCLIC COMPOUNDS HAVING ANTIINFLAMMATORY ACTIVITY
申请人:SCHERING CORPORATION
公开号:WO1989012637A1
公开(公告)日:1989-12-28
(EN) Heterobicyclic and heterocyclic intermediate compounds and their use in treating inflammation, hyperproliferative skin conditions such as psoriasis and allergy are disclosed.(FR) L'invention concerne des composés intermédiaires hétérobicycliques hétérocycliques ainsi que leur utilisation dans le traitement anti-inflammatoire d'états cutanés hyperprolifératifs tels que le psoriasis et l'allergie.
Heterobicyclic compounds having antiinflammatory activity
申请人:Schering Corporation
公开号:US05182289A1
公开(公告)日:1993-01-26
Heterobicyclic and heterocyclic intermediate compounds and their use in treating inflammation, hyperproliferative skin conditions such as psoriasis and allergy are disclosed.